We plan to develop human and animal stem cell therapy using the FreSHtracer™ platform and license them out.
Separation of stem cells from various donors
Culture high-quality stem cells
Stem cells with enhanced anti-inflammatory and immunosuppressive functions
Clinical phase 1/2a
Global Big Pharma
Joint large scale clinical trials
Reinvestment in back-up pipelines (expanded indications of cell therapy)